Your shopping cart is currently empty

ARV-393 is a PROTAC degrader targeting BCL6 with the advantage of being highly potent and orally available.ARV-393 recruits BCL6 and E3 ligase cerebellum to rapidly degrade BCL6 through the cell's natural ubiquitin proteasome system for the treatment of diffuse large b-cell lymphoma (DLBCL) and non-Hodgkin's lymphoma (NHL).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $223 | - | In Stock | |
| 5 mg | $562 | - | In Stock | |
| 10 mg | $892 | - | In Stock | |
| 25 mg | $1,820 | - | In Stock | |
| 50 mg | $2,830 | - | In Stock |
| Description | ARV-393 is a PROTAC degrader targeting BCL6 with the advantage of being highly potent and orally available.ARV-393 recruits BCL6 and E3 ligase cerebellum to rapidly degrade BCL6 through the cell's natural ubiquitin proteasome system for the treatment of diffuse large b-cell lymphoma (DLBCL) and non-Hodgkin's lymphoma (NHL). |
| In vitro | ARV-393 demonstrated potent activity in multiple diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL) cell lines, with both DC₅₀ and GI₅₀ values < 1 nM [1]. |
| In vivo | In xenograft models, mice were orally administered ARV-393 (3, 10, 30 mg/kg; once daily; for 23 days) to evaluate its in vivo antitumor activity in lymphoma. ARV-393 significantly inhibited tumor growth. [2] |
| Synonyms | ARV393 |
| Molecular Weight | 898.42 |
| Formula | C46H53ClFN9O7 |
| Cas No. | 2851885-95-3 |
| Smiles | FC1=C2C(C(=O)N(C2)C3C(=O)NC(=O)CC3)=CC=C1C4CCN(CC4)[C@@H]5C[C@@H](OC6CCN(CC6)C=7N=C(NC=8C=C9C(=CC8)N(C(C)C)C(=O)C(OCC(NC)=O)=C9)C(Cl)=CN7)C5 |
| Relative Density. | 1.45 g/cm3 at 20℃ (Predicted) |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||
| Solubility Information | DMSO: 8 mg/mL (8.9 mM), Sonication is recommended. | |||||||||||||||
Solution Preparation Table | ||||||||||||||||
DMSO
| ||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.